In the News | Citizen Health Press Highlights

The panel, featuring Craig Lipset from the Decentralized Trials & Research Alliance, Deirdre BeVard of CSL Innovation GmbH, Heidi Bjornson-Pennell from the Chan Zuckerberg Initiative (CZI), Nasha Fitter of Citizen Health, Craig Martin from the Orphan Therapeutics Accelerator, and Tracey Sikora from the National Organization for Rare Disorders (NORD), explored how patients are evolving from passive participants to active leaders in drug development.

With a vision rooted in compassion and innovation, Nasha Fitter continues to inspire change and hope for those navigating the challenges of rare diseases. Check out Nasha Fitter’s exclusive interview with Eqvista.

FirstWord reached out to three companies, each offering different healthtech and digital health solutions but whose technologies are wholly dependent on a robust AI infrastructure, to get their initial views on Stargate, what challenges might the project face and critical factors that would help it achieve success.

They "generously contributed expertise that spanned consumer, clinical, technical, policy and operational points of view so that we could present a unified view of a multi-faceted issue," Deven McGraw of Citizen Health, cochair, said in a statement.

The Privacy & Consent workgroup was formed, led by co-chairs Deven McGraw of Citizen Health, and Dr. Steven Lane, chief medical officer of Health Gorilla.

According to the CB Insights State of Digital Health 2024 Report, 22 startups across the globe successfully raised early-stage funding (Angel, Pre-Seed, Seed, and Series A) in the fourth quarter of 2024.

Farid Vij and Nasha Fitter, co-founders of Citizen Health, discuss how their organization helps rare disease patients.

We spoke to Citizen Health Co-Founders Farid Vij and Nasha Fitter about the evolution of Citizen Health, what it will enable, and how it is helping shift power towards patients and their caregivers in the pursuit of new therapies.

By leveraging AI, Citizen Health aims to reduce therapy advancement timelines and provide personalized health insights for rare disease patients.

The funding round was led by Transformation Capital, with participation from Wavemaker 360 and prominent angel investors. This fundraise is further strengthened by a strategic program investment and partnership with the Chan Zuckerberg Initiative (CZI).

Citizen Health emerged from stealth on Tuesday, announcing $14.5 million in seed funding and a partnership with the Chan Zuckerberg Initiative (CZI) to drive rare disease drug development.

A Palo Alto health care startup previously known as Ciitizen has relaunched as Citizen Health after being spun out of Invitae last year.